Related Experiment Video
Updated: Sep 9, 2025

Author Spotlight: THP-1 Macrophage Response to LPS/ATP — Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum
Published on: May 3, 2024
A Comprehensive Review of Food-Derived Compounds Targeting Pyroptosis for Colitis Therapy: From Effects to Mechanisms
Jin-Wei Zhao1, Lu-Yao Li1, Fang-Wang Ye1
1Department of Hepatopancreatobiliary Surgery, The Second Hospital of Jilin University, Changchun, Jilin, 130022, People's Republic of China.
Abstract:
Ulcerative colitis (UC) is a form of non-specific inflammatory bowel disease characterized by complex pathological mechanisms that remain incompletely understood, posing challenges for effective treatment. Pyroptosis, a form of inflammatory cell death mediated by the Gasdermin D protein family, occurs primarily through the classical caspase-1 pathway, the non-classical caspase-4, 5, and 11 pathways, and alternative pathways. Dysregulated activation of pyroptosis signaling has been implicated in the progression of UC, indicating that targeted inhibition of pyroptosis may serve as a therapeutic strategy. Food-derived compounds have demonstrated promise in modulating key pyroptosis-related targets, thereby providing potential therapeutic benefits for UC. This review examines the classical, non-classical, and alternative pathways of pyroptosis and their roles in UC pathogenesis and treatment. Additionally, the effects and mechanisms of action of natural compounds in targeting programmed cell death are discussed, with the aim of informing future therapeutic strategies and contributing to the development of new pharmacological interventions for UC.
Insights
Ulcerative colitis (UC) involves complex inflammation. Targeting pyroptosis, a cell death process, using food-derived compounds shows promise for new UC treatments.
Area of Science:
- Gastroenterology
- Immunology
- Pharmacology
Background:
- Ulcerative colitis (UC) is an inflammatory bowel disease with incompletely understood pathology, complicating treatment.
- Pyroptosis, a pro-inflammatory programmed cell death, is mediated by Gasdermin D and involves caspase pathways.
- Dysregulated pyroptosis signaling is linked to UC progression, suggesting it as a therapeutic target.
Purpose of the Study:
- To review pyroptosis pathways (classical, non-classical, alternative) and their role in UC.
- To explore the therapeutic potential of food-derived compounds in modulating pyroptosis for UC.
- To inform the development of novel pharmacological interventions for UC.
Main Methods:
- Literature review of pyroptosis mechanisms and pathways.
- Analysis of studies on natural compounds targeting programmed cell death in UC.
- Examination of pyroptosis signaling in UC pathogenesis and treatment.
Main Results:
- Pyroptosis activation is implicated in UC pathogenesis.
- Natural compounds show potential in modulating pyroptosis-related targets.
- Targeting pyroptosis offers a promising therapeutic avenue for UC.
Conclusions:
- Understanding pyroptosis pathways is crucial for UC treatment.
- Food-derived compounds represent a potential therapeutic strategy for UC by targeting pyroptosis.
- Further research into natural compounds can lead to new UC pharmacological interventions.
More Related Videos
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

